Q1 2025 13F Holders as of 31 Mar 2025
-
Type / Class
-
Equity / COMMON STOCK
-
Total 13F shares
-
349,464
-
Share change
-
+296,771
-
Total reported value
-
$303,734
-
Price per share
-
$0.87
-
Number of holders
-
15
-
Value change
-
+$250,855
-
Number of buys
-
11
-
Number of sells
-
1
Institutional Holders of IMPACT BIOMEDICAL INC. - COMMON STOCK (IBO) as of Q1 2025
As of 31 Mar 2025,
IMPACT BIOMEDICAL INC. - COMMON STOCK (IBO) was held by
15 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
349,464 shares.
The largest 10 holders included
VANGUARD GROUP INC, HRT FINANCIAL LP, CITADEL ADVISORS LLC, BlackRock, Inc., GEODE CAPITAL MANAGEMENT, LLC, UBS Group AG, STATE STREET CORP, MORGAN STANLEY, Tower Research Capital LLC (TRC), and WELLS FARGO & COMPANY/MN.
This page lists
15
institutional shareholders reporting positions in this security
for the Q1 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.